The Prevalence and Significance of Overt Disseminated Intravascular Coagulation in Patients with Septic Shock in the Emergency Department According to the Third International Consensus Definition
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The prevalence and prognostic value of overt disseminated intravascular coagulation (DIC) in patients with septic shock presenting to emergency departments (EDs) is poorly understood, particularly following the release of a new definition of septic shock. The purpose of this study was to investigate the prevalence and prognostic value of DIC in septic shock. Methods: We performed retrospective review of 391 consecutive patients with septic shock admitting to the ED of tertiary care, university-affiliated hospital during a 16-month. Septic shock was defined as fluid-unresponsive hypotension requiring vasopressor to maintain a mean arterial pressure of 65 mmHg or greater, and serum lactate level ≥ 2 mmol/L. Overt DIC was defined as an International Society on Thrombosis and Hemostasis (ISTH) score ≥ 5 points. The primary endpoint was 28-day mortality. Results: Of 391 patients with septic shock, 290 were included in the present study. The mean age was 65.6 years, the 28-day mortality rate was 26.9%, and the prevalence of overt DIC was 17.6% (n = 51) according to the ISTH score. The median DIC score was higher in non-survivors than in survivors (5.0 vs. 2.0, p = 0.001). Significant higher risk of mortality was observed in overt DIC patients compared to those without (28.2% vs. 13.7%, p = 0.005). Multivariable logistic regression analysis identified DIC to be independently associated with 28-day mortality (odds ratio, 2.689 [95% confidence interval, 1.390-5.201]). Conclusions: Using the ISTH criteria of DIC, overt DIC in septic shock was found to be common among patients admitting to the ED and to be associated with higher mortality when it is accompanied with septic shock. Efforts are required to identify presence of overt DIC during the initial treatment of septic shock in patients presenting the the ED.
Abstract
Background: The prevalence and prognostic value of overt disseminated intravascular coagulation (DIC) in patients with septic shock presenting to emergency departments (EDs) is poorly understood, particularly following the release of a new definition of septic shock. The purpose of this study was to investigate the prevalence and prognostic value of DIC in septic shock. Methods: We performed retrospective review of 391 consecutive patients with septic shock admitting to the ED of tertiary care, university-affiliated hospital during a 16-month. Septic shock was defined as fluid-unresponsive hypotension requiring vasopressor to maintain a mean arterial pressure of 65 mmHg or greater, and serum lactate level ≥ 2 mmol/L. Overt DIC was defined as an International Society on Thrombosis and Hemostasis (ISTH) score ≥ 5 points. The primary endpoint was 28-day mortality. Results: Of 391 patients with septic shock, 290 were included in the present study. The mean age was 65.6 years, the 28-day mortality rate was 26.9%, and the prevalence of overt DIC was 17.6% (n = 51) according to the ISTH score. The median DIC score was higher in non-survivors than in survivors (5.0 vs. 2.0, p = 0.001). Significant higher risk of mortality was observed in overt DIC patients compared to those without (28.2% vs. 13.7%, p = 0.005). Multivariable logistic regression analysis identified DIC to be independently associated with 28-day mortality (odds ratio, 2.689 [95% confidence interval, 1.390-5.201]). Conclusions: Using the ISTH criteria of DIC, overt DIC in septic shock was found to be common among patients admitting to the ED and to be associated with higher mortality when it is accompanied with septic shock. Efforts are required to identify presence of overt DIC during the initial treatment of septic shock in patients presenting the the ED.
참고문헌 (20)
- Dombrovskiy VY, "Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003", Crit Care Med, 35, pp.1244~1250 (2007)
- Kim WY, "Analysis of progression in risk, injury, failure, loss, and end-stage renal disease classification on outcome in patients with severe sepsis and septic shock", J Crit Care, 27(104), pp.e1~e7 (2012)
- Ryoo SM, "Prognostic value of B-type natriuretic peptide with the sequential organ failure assessment score in septic shock", Am J Med Sci, 349, pp.287~291 (2015)
- Ryoo SM, "Prognostic value of timing of antibiotic administration in patients with septic shock treated with early quantitative resuscitation", Am J Med Sci, 349, pp.328~333 (2015)
- Singer M, "The third international consensus definitions for sepsis and septic shock (sepsis-3)", JAMA, 315, pp.801~810 (2016)
- Yin Q, "Prognostic value of the International Society on Thrombosis and Haemostasis scoring system for overt disseminated intravascular coagulation in emergency department sepsis", Infection, 42, pp.629~637 (2014)
- Levi M, "Disseminated intravascular coagulation", Crit Care Med, 35, pp.2191~2195 (2007)
- Dhainaut JF, "Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure", Crit Care Med, 33, pp.341~348 (2005)
- Voves C, "International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients", Blood Coagul Fibrinolysis, 17, pp.445~451 (2006)
- Seymour CW, "Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3)", JAMA, 315, pp.762~774 (2016)
- Gando S, "A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis", Crit Care, 17, pp.R111~ (2013)
- Dellinger RP, "Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock: 2012", Crit Care Med, 41, pp.580~637 (2013)
- Ogawa Y, "Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis", J Trauma Acute Care Surg, 72, pp.1150~1157 (2012)
- Kienast J, "Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation", J Thromb Haemost, 4, pp.90~97 (2006)
- Bernard GR, "Efficacy and safety of recombinant human activated protein C for severe sepsis", N Engl J Med, 344, pp.699~709 (2001)
- Dhainaut JF, "Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation", J Thromb Haemost, 2, pp.1924~1933 (2004)
- Levi M, "Another step in improving the diagnosis of disseminated intravascular coagulation in sepsis", Crit Care, 17, pp.448~ (2013)
- Bakhtiari K, "Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation", Crit Care Med, 32, pp.2416~2421 (2004)
- Angstwurm MW, "New disseminated intravascular coagulation score: a useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores", Crit Care Med, 34, pp.314~320 (2006)
- Takemitsu T, "Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation", Thromb Haemost, 105, pp.40~44 (2011)